SELLAS Life Sciences Group (SLS) Institutional Ownership $1.62 +0.07 (+4.52%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$1.62 -0.01 (-0.31%) As of 05/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for SELLAS Life Sciences Group (NASDAQ:SLS)CurrentInstitutional OwnershipPercentage17.38%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$8.00MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$70.03K Get SLS Insider Trade Alerts Want to know when executives and insiders are buying or selling SELLAS Life Sciences Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLS Institutional Buying and Selling by Quarter SELLAS Life Sciences Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/28/2025Brooklyn FI LLC594,919$677K0.1%N/A0.845% 2/17/2025Anson Funds Management LP1,192,266$1.24M0.1%+50.2%1.694% 2/14/2025Northern Trust Corp134,721$140K0.0%+33.6%0.191% 2/13/2025XTX Topco Ltd53,426$56K0.0%-14.9%0.076% 2/12/2025Geode Capital Management LLC733,546$763K0.0%+21.2%1.042% 2/11/2025Virtu Financial LLC41,155$43K0.0%-48.1%0.058% 2/11/2025Brooklyn FI LLC594,919$677K0.0%N/A0.845% 1/31/2025 Opus Capital Group LLC238,500$248K0.0%+5.5%0.339% 11/20/2024Virtu Financial LLC79,241$99K0.0%+24.1%0.113% 11/16/2024Geode Capital Management LLC605,191$757K0.0%+17.1%0.941% Get the Latest News and Ratings for SLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024Anson Funds Management LP793,835$992K0.0%N/A1.234% 11/15/2024XTX Topco Ltd62,785$78K0.0%N/A0.098% 11/15/2024State Street Corp174,529$218K0.0%+30.2%0.271% 8/9/2024Renaissance Technologies LLC32,446$39K0.0%N/A0.056% 5/20/2024Virtu Financial LLC39,429$40K0.0%-34.2%0.068% 5/14/2024Anson Funds Management LP4,832,368$4.88M0.3%N/A8.366% 4/26/2024 Opus Capital Group LLC200,600$203K0.0%+48.6%0.356% 2/13/2024Armistice Capital LLC820,000$869K0.0%N/A2.558% 1/31/2024 Opus Capital Group LLC135,000$143K0.0%+291.3%0.421% 9/12/2023Prosperity Financial Group Inc.29,800$47K0.0%N/A0.105% 5/11/2023Highbridge Capital Management LLC1,805,054$2.58M0.0%N/A6.367% 1/18/2023 Opus Capital Group LLC19,672$46K0.0%N/A0.096% 11/15/2022Empery Asset Management LP308,466$623K3.7%-66.8%1.501% 2/14/2022GSA Capital Partners LLP10,447$58K0.0%N/A0.066% 2/11/2022Equitable Holdings Inc.102,000$564K0.0%+2.0%0.642% 11/12/2021Jump Financial LLC14,627$134K0.0%N/A0.092% 11/12/2021Equitable Holdings Inc.100,000$916K0.0%+6.0%0.630% 11/12/2021Geode Capital Management LLC133,801$1.23M0.0%+32.0%0.843% 8/25/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.533% 8/17/2021Price T Rowe Associates Inc. MD15,500$172K0.0%-42.8%0.103% 8/16/2021Morgan Stanley15,499$172K0.0%+297.4%0.103% 8/16/2021Pinz Capital Management LP10,700$119K0.0%-18.3%0.071% 8/16/2021State Street Corp37,468$416K0.0%N/A0.248% 8/16/2021Marshall Wace LLP84,544$938K0.0%+63.0%0.560% 8/13/2021Northern Trust Corp24,605$273K0.0%+35.9%0.163% 8/13/2021Geode Capital Management LLC101,337$1.12M0.0%+6.8%0.672% 8/13/2021Vanguard Group Inc.618,534$6.87M0.0%+31.6%4.100% 8/12/2021Dimensional Fund Advisors LP20,320$226K0.0%+31.9%0.135% 8/12/2021Bank of Montreal Can109,282$1.43M0.0%N/A0.724% 8/11/2021 Bank of New York Mellon Corp20,332$226K0.0%+30.3%0.135% Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why(Data available from 1/1/2016 forward) SLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLS shares? During the previous two years, 12 institutional investors and hedge funds held shares of SELLAS Life Sciences Group. The most heavily invested institutionals were Highbridge Capital Management LLC ($2.58M), Anson Funds Management LP ($1.24M), Armistice Capital LLC ($869K), Geode Capital Management LLC ($763K), Brooklyn FI LLC ($677K), Opus Capital Group LLC ($248K), and State Street Corp ($218K).Learn more on SLS's institutional investors. What percentage of SELLAS Life Sciences Group stock is owned by institutional investors? 17.38% of SELLAS Life Sciences Group stock is owned by institutional investors. Learn more on SLS's institutional investor holdings. Which institutional investors have been buying SELLAS Life Sciences Group stock? Of the 12 institutional investors that purchased SELLAS Life Sciences Group stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Anson Funds Management LP ($6.02M), Highbridge Capital Management LLC ($1.81M), Brooklyn FI LLC ($1.19M), Armistice Capital LLC ($820K), Geode Capital Management LLC ($216.54K), Opus Capital Group LLC ($178.50K), and XTX Topco Ltd ($62.79K). How much institutional buying is happening at SELLAS Life Sciences Group? Institutional investors have bought a total of 10,449,371 shares in the last 24 months. This purchase volume represents approximately $11.67M in transactions. Which SELLAS Life Sciences Group major shareholders have been selling company stock? The following institutional investors have sold SELLAS Life Sciences Group stock in the last 24 months: Virtu Financial LLC ($58.57K), and XTX Topco Ltd ($9.36K). How much institutional selling is happening at SELLAS Life Sciences Group? Institutional investors have sold a total of 67,930 shares in the last 24 months. This volume of shares sold represents approximately $70.03K in transactions. Related Companies Relay Therapeutics Major Shareholders Stoke Therapeutics Major Shareholders Sage Therapeutics Major Shareholders Maravai LifeSciences Major Shareholders MeiraGTx Major Shareholders UroGen Pharma Major Shareholders Tourmaline Bio Major Shareholders Mind Medicine (MindMed) Major Shareholders Ginkgo Bioworks Major Shareholders SIGA Technologies Major Shareholders This page (NASDAQ:SLS) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SELLAS Life Sciences Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SELLAS Life Sciences Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.